颈动脉内膜切除术后围手术期之外同侧缺血事件的可调控危险因素
基于VQI数据库2003年1月至2022年5月的171,816例颈动脉内膜切除术(CEA),筛选126,290例分析初始住院后同侧缺血性卒中或短暂性脑缺血发作(TIA)。Cox回归显示未放置补片(HR 18.24)、随访期未用抗血小板药(HR 9.75)、随访期未用他汀(HR 3.18)等与事件相关。补片成形和持续抗血小板、他汀治疗可显著降低远期同侧缺血事件。
要点
- CEA部位未放置补片与远期同侧缺血事件强相关(HR 18.24,P<.0001)。
- 随访期未用抗血小板药(HR 9.75)和未用他汀(HR 3.18)与同侧缺血事件相关。
- 补片放置者随访期无同侧缺血事件比例为99.8%,未放置者为5.7%。
核心结论
- 补片血管成形关闭对CEA后远期同侧脑缺血事件有显著保护作用。
- CEA后出院及维持抗血小板和他汀治疗显著降低未来同侧缺血事件发生率。
- 改善上述措施的实施可显著提升CEA预后。
研究设计与样本
- 回顾性队列研究,查询VQI数据库2003年1月至2022年5月所有CEA共171,816例。
- 排除随访数据不足30天、同期冠脉搭桥、同期近端或远端颈动脉干预、同期其他动脉干预及初始住院期间卒中或TIA后,纳入126,290例分析。
- 主要结局为初始住院后CEA同侧大脑半球的缺血性卒中或TIA。
- 采用χ2检验筛选变量,年龄用Student t检验作为有序变量评估,单变量P≤.05的变量纳入多变量Cox回归时间-事件分析。
- 对Cox回归中最显著变量构建Kaplan-Meier曲线作为视觉辅助。
主要发现
- Cox回归中与初始CEA住院后同侧大脑半球缺血事件显著相关的变量:CEA部位未放置补片(HR 18.24,P<.0001)。
- 随访期未用抗血小板治疗(HR 9.75,P<.0001);随访期未用他汀治疗(HR 3.18,P<.001);出院时未用他汀治疗(HR 1.25,P=.015)。
- 随访期抗凝治疗(HR 1.53,P<.001);复发狭窄>70%(HR 2.15,P<.001);手术中使用分流(HR 1.20,P=.007)。
- 手术放置补片者和随访期确认抗血小板治疗者随访期CEA同侧无缺血事件比例分别为99.8%和99.6%。
- 手术未放置补片者和随访期未接受抗血小板治疗者同侧缺血事件阳性率分别为5.7%和4.7%(两者P<.0001)。
临床怎么用
- 作者认为补片血管成形关闭对CEA后远期同侧脑缺血事件有显著保护作用。
- 作者认为CEA后出院及维持抗血小板和他汀治疗显著降低未来同侧缺血事件发生率。
- 作者指出改善这些措施的实施可显著提升CEA预后。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The purpose of this study was to quantify the effects of several modifiable variables on the occurrence of stroke after the initial perioperative period for patients who had undergone carotid endarterectomy (CEA). METHODS: The primary outcome for the present study was the development of an ischemic stroke or transient ischemic attack (TIA) in the cerebral hemisphere ipsilateral to CEA after the initial hospitalization. All CEAs in the VQI between January 2003 and May 2022 were queried. We identified 171,816 CEAs in the database. The exclusion criteria for the study were the lack of follow-up data for >30 days, concomitant coronary artery bypass surgery, concomitant proximal or distal carotid intervention at CEA, other arterial interventions at CEA, and stroke or TIA during the initial hospital admission, leaving 126,290 patients for analysis. We used the χ2 test for statistical analysis of the outcome of ipsilateral ischemic stroke or TIA after the initial CEA hospital admission to determine the relevant variables. Age was evaluated as an ordinal variable using the Student t test. Variables with P ≤ .05 on univariable analysis were included in the multivariable Cox regression time-to-event analysis for the primary outcome. Kaplan-Meier curves were constructed of the most significant variables on Cox regression as a visual aid. RESULTS: The following variables achieved significance on Cox regression for an association with development of ipsilateral hemispheric ischemic events after the index CEA hospital admission: lack of patch placement at CEA site (hazard ratio [HR], 18.24; P < .0001), lack of antiplatelet therapy at long-term follow-up (LTFU; HR, 9.75; P < .0001), lack of statin therapy at LTFU (HR, 3.18; P < .001), lack of statin therapy at hospital discharge (HR, 1.25; P = .015), anticoagulation at LTFU (HR, 1.53; P < .001), development of >70% recurrent stenosis (HR, 2.15; P < .001), and shunt use at surgery (HR, 1.20; P = .007). Patients with patch placement at surgery and patients with confirmed antiplatelet therapy at LTFU had had 99.8% and 99.6% freedom from an ischemic event ipsilateral to the side of the CEA at LTFU, respectively. This finding is in contrast to the 5.7% and 4.7% positivity for ischemic events for those without patch placement at surgery and those not receiving antiplatelet therapy at LTFU, respectively (P < .0001 for both). CONCLUSIONS: Performance of patch angioplasty arterial closure was remarkably protective against ipsilateral cerebral ischemic events at LTFU after CEA. Discharging and maintaining patients with antiplatelet and statin medication after CEA significantly reduces the incidence of future ipsilateral ischemic events. Thus, a significant opportunity exists for enhanced outcomes with improved implementation of these measures.
引用
- Blecha M, DeJong M, Nam J, et al. Modifiable risk factors for occurrence of ipsilateral ischemic events after carotid endarterectomy beyond perioperative period. J Vasc Surg. 2022. PMID: 36181995. doi:10.1016/j.jvs.2022.09.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。